ArticleSexual medicine2026
The effect of Bartholin gland diseases on female sexual function, sexual distress, and genital self-image: a prospective cohort study.
Article in Sexual medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bartholin gland disease impairs sexual function, yet most studies focus on surgical technique rather than the broader sexual health burden, and none has systematically examined sexual distress or genital self-image in this population. We aimed to characterize the sexual health burden of Bartholin gland disease across four domains: pain (Visual Analogue Scale [VAS]), sexual function (Female Sexual Function Index [FSFI]), sexual distress (Female Sexual Distress Scale-Revised [FSDS-R]), and genital self-image (Female Genital Self-Image Scale [FGSIS]), at two time points (before and after treatment) and to compare findings against matched healthy controls. Methods: This prospective cohort study enrolled 25 women diagnosed with a Bartholin gland cyst or abscess (patient group) and 25 age-matched healthy controls at a single training and research hospital. Patients were evaluated twice: at presentation before any treatment (T1) and after symptom resolution (T2). Controls were assessed once. Outcome measures were the VAS (applied to patients only), FSFI (cut-off <26.55), FSDS-R (cut-off ≥11), and FGSIS. Sample size was calculated a priori (d = 0.80, α = 0.05, power = 80%; G Results and Discussion: Groups were comparable for age (36.1 ± 6.6 vs. 34.2 ± 7.6 years,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.